| Crystal structure of SARS-CoV-2 main protease in complex with the non-covalent inhibitor ML188 GJ Lockbaum, AC Reyes, JM Lee, R Tilvawala, EA Nalivaika, A Ali, ... Viruses 13 (2), 174, 2021 | 99 | 2021 |
| Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance AM Shaqra, SN Zvornicanin, QYJ Huang, GJ Lockbaum, M Knapp, ... Nature communications 13 (1), 3556, 2022 | 63 | 2022 |
| Drug design strategies to avoid resistance in direct-acting antivirals and beyond AN Matthew, F Leidner, GJ Lockbaum, M Henes, J Zephyr, S Hou, ... Chemical reviews 121 (6), 3238-3270, 2021 | 44 | 2021 |
| Picomolar to micromolar: elucidating the role of distal mutations in HIV-1 protease in conferring drug resistance M Henes, GJ Lockbaum, K Kosovrasti, F Leidner, GS Nachum, ... ACS chemical biology 14 (11), 2441-2452, 2019 | 41 | 2019 |
| Structural adaptation of darunavir analogues against primary mutations in HIV-1 protease GJ Lockbaum, F Leidner, LN Rusere, M Henes, K Kosovrasti, GS Nachum, ... ACS infectious diseases 5 (2), 316-325, 2018 | 32 | 2018 |
| Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2 S Mondal, Y Chen, GJ Lockbaum, S Sen, S Chaudhuri, AC Reyes, ... Journal of the American Chemical Society 144 (46), 21035-21045, 2022 | 27 | 2022 |
| Pan-3C protease inhibitor rupintrivir binds SARS-CoV-2 main protease in a unique binding mode GJ Lockbaum, M Henes, JM Lee, J Timm, EA Nalivaika, PR Thompson, ... Biochemistry 60 (39), 2925-2931, 2021 | 24 | 2021 |
| HIV-1 protease inhibitors incorporating stereochemically defined P2′ ligands to optimize hydrogen bonding in the substrate envelope LN Rusere, GJ Lockbaum, SK Lee, M Henes, K Kosovrasti, E Spielvogel, ... Journal of medicinal chemistry 62 (17), 8062-8079, 2019 | 24 | 2019 |
| Molecular determinants of epistasis in HIV-1 protease: Elucidating the interdependence of L89V and L90M mutations in resistance M Henes, K Kosovrasti, GJ Lockbaum, F Leidner, GS Nachum, ... Biochemistry 58 (35), 3711-3726, 2019 | 20 | 2019 |
| Quinoxaline-based linear HCV NS3/4A protease inhibitors exhibit potent activity against drug resistant variants LN Rusere, AN Matthew, GJ Lockbaum, M Jahangir, A Newton, ... ACS Medicinal Chemistry Letters 9 (7), 691-696, 2018 | 18 | 2018 |
| Avoiding drug resistance by substrate envelope-guided design: Toward potent and robust HCV NS3/4A protease inhibitors AN Matthew, J Zephyr, D Nageswara Rao, M Henes, W Kamran, ... MBio 11 (2), 10.1128/mbio. 00172-20, 2020 | 16 | 2020 |
| Inhibiting HTLV-1 protease: a viable antiviral target GJ Lockbaum, M Henes, N Talledge, LN Rusere, K Kosovrasti, ... ACS chemical biology 16 (3), 529-538, 2021 | 15 | 2021 |
| Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance E Spielvogel, SK Lee, S Zhou, GJ Lockbaum, M Henes, A Sondgeroth, ... Elife 12, e80328, 2023 | 14 | 2023 |
| Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses WD Harshbarger, D Deming, GJ Lockbaum, N Attatippaholkun, ... Nature Communications 12 (1), 559, 2021 | 12 | 2021 |
| Structural analysis of potent hybrid HIV-1 protease inhibitors containing Bis-tetrahydrofuran in a Pseudosymmetric dipeptide Isostere LN Rusere, GJ Lockbaum, M Henes, SK Lee, E Spielvogel, DN Rao, ... Journal of medicinal chemistry 63 (15), 8296-8313, 2020 | 5 | 2020 |
| Avoiding drug resistance by substrate envelope-guided design: toward potent and robust HCV NS3/4A protease inhibitors. mBio 11 (2): e00172-20 AN Matthew, J Zephyr, D Nageswara Rao, M Henes, W Kamran, ... | 5 | 2020 |
| HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues GJ Lockbaum, LN Rusere, M Henes, K Kosovrasti, DN Rao, E Spielvogel, ... European Journal of Medicinal Chemistry 257, 115501, 2023 | 3 | 2023 |
| Optimizing the refinement of merohedrally twinned P61 HIV-1 protease–inhibitor cocrystal structures GJ Lockbaum, F Leidner, WE Royer, N Kurt Yilmaz, CA Schiffer Acta Crystallographica Section D: Structural Biology 76 (3), 302-310, 2020 | 2 | 2020 |
| Correction to Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease GJ Lockbaum, F Leidner, LN Rusere, M Henes, K Kosovrasti, GS Nachum, ... ACS infectious diseases 5 (6), 1044-1044, 2019 | 1 | 2019 |
| Structural adaptation of Darunavir analogs against primary resistance mutations in HIV-1 protease GJ Lockbaum, F Leidner, LN Rusere, M Henes, K Kosovrasti, ... BioRxiv, 406637, 2018 | 1 | 2018 |
Celia A SchifferProfessor and Chair of Biochemistry and Molecular Biotechnology, U Mass Chan Medical SchoolVerified email at umassmed.edu
